发明人刘建华,郭海燕,孙丽萍. "Method for the Synthesis of Allisartan Isoproxil Impurity 13" [P]. 中国发明专利, 专利号 CN 115853460 B, 授权公告日 2020-07-21.
Schröder R, O'Brien P Q, Patel M V. "A Process for Preparing High-Purity Allisartan Isoproxil Impurity 13" [P]. US Patent, US 10203489 B2, 2025-02-18.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of 阿利沙坦酯杂质13 in Pharmaceutical Formulations". Environ. Sci. Technol., 2011, 1869, (2), 6732-6759.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿利沙坦酯杂质13 as an Impurity". J. Pharm. Biomed. Anal., 2023, 1678, (10), 8612-8624.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Allisartan Isoproxil Impurity 13 Using HRMS and NMR". Phytochemistry, 2022, 2441, 7837-7842.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate 阿利沙坦酯杂质13 Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2017, 2456, (8), 5851-5869.